tag:blogger.com,1999:blog-305817752011-04-22T10:59:56.488+05:30INITIATIVE FOR MEDICINES, ACCESS & KNOWLEDGE (I-MAK)<br> <br> I-MAK is an initiative to bring new and practical perspectives to issues impacting medicines, access and knowledge.Tahirhttp://www.blogger.com/profile/16629715446740927556noreply@blogger.comBlogger21100tag:blogger.com,1999:blog-30581775.post-58471089175840483422007-08-25T06:40:00.000+05:302007-08-25T06:57:20.678+05:30We are pleased to announce that the Initiative for Medicines, Access &amp; Knowledge (I-MAK) website is now up and accessible through www.i-mak.org. All our current and future work will be available at www.i-mak.org from now on.<br /><br />Thanks!<div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/30581775-5847108917584048342?l=i-mak-org.blogspot.com' alt='' /></div>Tahirhttp://www.blogger.com/profile/16629715446740927556noreply@blogger.com0tag:blogger.com,1999:blog-30581775.post-1152008677273360352006-07-04T15:12:00.000+05:302006-07-05T18:18:22.063+05:30India is currently debating whether to provide exclusivity for pharmaceutical test data. The various Ministries in the Government are planning to meet on 12 July 2006. I-MAK has produced a document which reviews the practical impact of the current proposals and provides recommendations which should be considered before a final decision is reached.<br /><br /><ul><br /><li><a href="http://imak.org.googlepages.com/I-MAK_Article39.pdf">The Impact of Article 39.3 in India: A Practical Perspective</a><br /></ul><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/30581775-115200867727336035?l=i-mak-org.blogspot.com' alt='' /></div>Tahirhttp://www.blogger.com/profile/16629715446740927556noreply@blogger.com1